Acion, L., Peterson, J. J., Temple, S., and Arndt, S. (2006), “Probabilistic
Index: An Intuitive Non-Parametric Approach to Measuring the
Size of Treatment Effects,” Statistics in Medicine, 25, 591–602. 303,
304
Al-Saleh, M. F. (2007), “On the Similarity Structure of Order Statistics,”
Communications in Statistics—Theory and Methods, 36,
1433–1439. 304
Bouckaert, A., and Mouchart, M. (2001), “Sure Outcomes of Random
Events: A Model for Clinical Trials,” Statistics in Medicine, 20,
521–543. 308
Brownie, C., Boos, D. D., and Hughes-Oliver, J. (1990), “Modifying
the T and Anova F Tests When Treatment Is Expected to Increase
Variability Relative to Controls,” Biometrics, 46, 259–266. 303
Brumback, L. C., Pepe, M. S., and Alonzo, T. A. (2006), “Using theRoc Curve for Gauging Treatment Effect in Clinical Trials,” Statistics
in Medicine, 25, 575–590. 304
Brunner, E., Domhof, S., and Langer, F. (2001), Nonparametric Analysis
of Longitudinal Data in Factorial Experiments, New York: Wiley.
304
Cohen, J. (1988), Statistical Power Analysis for the Behavioural Sciences,
Hillsdale, NJ: Laurence Erlbaum Associates. 303
Deeks, J. J. (2002), “Issues in the Selection of a Summary Statistic for
Meta-Analysis of Clinical Trials with Binary Outcomes,” Statistics
in Medicine, 21, 1575–1600. 307
DerSimonian, R., and Laird, N. (1986), “Meta-Analysis in Clinical Trials,”
Controlled Clinical Trials, 7, 177–188. 306
Glass, G. E. (1976), “Primary, Secondary and Meta-Analysis of Research,”
Educational Research, 5, 3–8. 303
Glasziou, P. P., and Irwig, L. M. (1995), “An Evidence Based Approach
to Individualising Treatment,” British Medical Journal, 311, 1356–
1359. 307
Greenland, S. (1987), “Interpretation and Choice of Effect Measures in
Epidemiologic Analyses,” American Journal of Epidemiology, 125,
761–768. 305, 307
Greenland, S., Schlesselman, J. J., and Criqui, M. H. (1986), “The Fallacy
of Employing Standardized Regression Coefficients and Correlations
as Measures of Effect,” American Journal of Epidemiology,
123, 203–208. 305
Greenland, S., Schlesselman, J. J., and Criqui, M. H. (1987), “Re:
‘The Fallacy of Employing Standardized Regression Coefficients
and Correlations as Measures of Effect’,” American Journal of Epidemiology,
125, 349–350. 305, 307
Grizzle, J. E., Starmer, C. F., and Koch, G. G. (1969), “Analysis of Categorical
Data by Linear Models,” Biometrics, 25, 489–504. 302
Hardy, R. J., and Thompson, S. G. (1996), “A Likelihood Approach
to Meta-Analysis with Random Effects,” Statistics in Medicine, 15,
619–629. 306
Hedges, L., and Olkin, I. (1985), Statistical Method for Meta-Analysis,
Orlando: Academic Press. 303
Hodges Jr, J. L., and Lehmann, E. L. (1963), “Estimates of Location
Based on Rank Tests,” The Annals of Mathematical Statistics, 34,
598–611. 306
Jung, J.W., and Koch, G. G. (1998), “A Linear Model Method for Rank
Measures of Association from Longitudinal Studies with Fixed Conditions
(Visits) for Data Collection and More Than Two Groups,”
Journal of Biopharmaceutical Statistics, 8, 299. 302
Jung, J. W., and Koch, G. G. (1999), “Multivariate Non-Parametric
Methods for Mann-Whitney Statistics to Analyse Cross-over Studies
with Two Treatment Sequences,” Statistics in Medicine, 18, 989–
1017. 302
Koch, G. G. (1972), “The Use of Non-Parametric Methods in the Statistical
Analysis of the Two-Period Change-over Design,” Biometrics,
28, 577–584. 302
Koch, G. G., Landis, J. R., Freeman, J. L., Freeman Jr, D. H., and
Lehnen, R. G. (1977), “A General Methodology for the Analysis
of Experiments with Repeated Measurement of Categorical Data,”
Biometrics, 33, 133–158. 302
Koch, G. G., McCanless, I., and Ward, J. F., Jr. (1984), “Interpretation
of Statistical Methodology Associated with Maintenance Trials,”
American Journal of Medicine, 77, 43–50. 306
Koch, G. G., Tangen, C. M., Jung, J. W., and Amara, I. A. (1998), “Issues
for Covariance Analysis of Dichotomous and Ordered Categorical
Data from Randomized Clinical Trials and Non-Parametric
Strategies for Addressing Them,” Statistics in Medicine, 17, 1863–
1892. 302, 304
Landis, J. R., and Koch, G. G. (1977a), “An Application of Hierarchical
Kappa-Type Statistics in the Assessment of Majority Agreementamong Multiple Observers,” Biometrics, 33, 363–374. 302
(1977b), “The Measurement of Observer Agreement for Categorical
Data,” Biometrics, 33, 159–174. 302
(1977c), “A One-Way Components of Variance Model for Categorical
Data,” Biometrics, 33, 671–679. 302
Lane, P.W., and Nelder, J. A. (1982), “Analysis of Covariance and Standardization
as Instances of Prediction,” Biometrics, 38, 613–621.
307
Lee, Y., and Nelder, J. A. (2004), “Conditional and Marginal Models:
Another View,” Statistical Science, 19, 219–228. 307
Lindsey, J. K., and Lambert, P. (1998), “On the Appropriateness of
Marginal Models for Repeated Measurements in Clinical Trials,”
Statistics in Medicine, 17, 447–469. 307
Moerman, D. (1983), “General Medical Effectiveness and Human Biology:
Placebo Effects in the Treatment of Ulcer Disease,” Medical
Anthropology Quarterly, 14, 3, 13–16. 306
Rom, D. M., and Hwang, E. (1996), “Testing for Individual and Population
Equivalence Based on the Proportion of Similar Responses”
[see comments], Statistics in Medicine, 15, 1489–1505. 304
Rucker, G., Schwarzer, G., Carpenter, J. R., and Schumacher, M.
(2008), “Undue Reliance on I(2) in Assessing Heterogeneity May
Mislead,” BMC Medical Research Methodology, 8, 79. 305
Schielzeth, H. (2010), “Simple Means to Improve the Interpretability
of Regression Coefficients,” Methods in Ecology and Evolution, 1,
103–113. 303, 305
Schmid, C. H., Lau, J., McIntosh, M. W., and Cappelleri, J. C. (1998),
“An Empirical Study of the Effect of the Control Rate as a Predictor
of Treatment Efficacy in Meta-Analysis of Clinical Trials,” Statistics
in Medicine, 17, 1923–1942. 307
Senn, S. J. (1997), “Testing for Individual and Population Equivalence
Based on the Proportion of Similar Responses” [Letter; Comment],
Statistics in Medicine, 16, 1303–1306. 304, 305
(2000), “The Many Modes of Meta,” Drug Information Journal,
34, 535–549. 303, 305
(2004a), “Added Values: Controversies Concerning Randomization
and Additivity in Clinical Trials,” Statistics in Medicine, 23,
3729–3753. 303, 305, 306, 307, 308
(2004b), “Conditional and Marginal Models: Another View—
Comments and Rejoinders,” Statistical Science, 19, 228–238. 307
(2006), “Letter to the Editor: Probabilistic Index: An Intuitive
Non-Parametric Approach to Measuring the Size of the Treatment
Effects by L. Acion, J. J. Peterson, S. Temple and S. Arndt,” Statistics
in Medicine, 25, 3944–3948. 305
Smeeth, L., Haines, A., and Ebrahim, S. (1999), “Numbers Needed to
Treat Derived from Meta-Analyses—Sometimes Informative, Usually
Misleading” [see comments], British Medical Journal, 318,
1548–1551. 307
Stine, R. A., and Heyse, J. F. (2001), “Non-Parametric Estimates of
Overlap,” Statistics in Medicine, 20, 215–236. 304
Tashkin, D. P., Celli, B. Senn, S., Burkhart, D., Kesten, S., Menjoge,
S. and Decrame, M. (2008), “A 4-Year Trial of Tiotropium
in Chronic Obstructive Pulmonary Disease,” New England Journal
of Medicine, 359, 1543–1554. 304
Weitzman, M. S. (1970), “Measures of Overlap of Income Distributions
of White and Negro Families in the United States,” US Bureau of the
Census. 304
Altmetric
Altmetric